CUHK_CCT00121
Effects of Different Dosages of intravitreal Bevacizumab (Avastin) for Neovascular Age-related Macular Degeneration: A Randomized Controlled Trial
2007-07-18
|
|
|
|
|
|---|---|---|---|
| 2011-02-08 | Complete | Administrator | Detail |
| 2009-11-24 | Complete | Registry User | Detail |
| 2009-11-19 | Recruiting | Administrator | Detail |
| 2007-07-18 | Recruiting | Registry User | Detail |